Medline Inc. Class A common stock (MDLN)

Price$33.61

Value ScoreC

Growth ScoreD

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (4W)-14.95%

VGM Score36.22

Market Capitalization$44.15B

P/E Ratio (Annual)38.10x

All Metrics

P/CF (Annual)25.32x

Book Value / Share (Quarterly)$8.58

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)9.85%

Cash Flow / Share (Quarterly)$1.23

Price vs S&P 500 (YTD)-28.13%

Gross Margin (TTM)25.86%

Net Profit Margin (TTM)3.32%

EPS (TTM)$1.19

10-Day Avg Trading Volume18.35M

EPS Excl Extra (TTM)$1.19

EPS (Annual)$1.43

ROI (Annual)4.97%

Gross Margin (Annual)26.44%

Cash / Share (Quarterly)$1.70

P/E Basic Excl Extra (TTM)45.71x

Revenue Growth QoQ (YoY)10.66%

P/E Normalized (Annual)38.10x

ROA (Last FY)3.01%

EBITD / Share (TTM)$3.38

Operating Margin (TTM)7.08%

Cash Flow / Share (Annual)$0.99

P/B Ratio3.92x

P/B Ratio (Quarterly)4.97x

Net Income / Employee (Annual)$25,800

Net Interest Coverage (TTM)2.39x

ROA (TTM)2.56%

EPS Growth QoQ (YoY)-36.19%

EPS Incl Extra (Annual)$1.43

Current Ratio (Annual)4.29x

Quick Ratio (Quarterly)2.51x

3-Month Avg Trading Volume7.63M

EV / Free Cash Flow (Annual)42.01x

P/E Incl Extra (TTM)45.71x

Revenue / Employee (TTM)$647,600

P/S Ratio (Annual)1.55x

Asset Turnover (Annual)0.74x

52-Week High$50.88

EPS Excl Extra (Annual)$1.43

Quick Ratio (Annual)2.37x

13-Week Price Return-23.70%

Total Debt / Equity (Annual)1.17x

Current Ratio (Quarterly)4.41x

Enterprise Value$54.49B

Asset Turnover (TTM)0.77x

Revenue / Employee (Annual)$631,800

Pretax Margin (Annual)4.39%

Cash / Share (Annual)$1.48

3-Month Return Std Dev40.84%

Net Income / Employee (TTM)$21,500

ROE (Last FY)10.79%

Net Interest Coverage (Annual)2.50x

EPS Basic Excl Extra (Annual)$1.43

P/FCF (TTM)27.37x

EV / Free Cash Flow (TTM)33.78x

Total Debt / Equity (Quarterly)1.12x

EPS Incl Extra (TTM)$1.19

ROI (TTM)3.38%

P/S Ratio (TTM)1.52x

Revenue / Share (Annual)$35.01

Forward P/E22.19x

P/E Ratio (TTM)45.71x

Year-to-Date Return-19.98%

5-Day Price Return-5.99%

EPS Normalized (Annual)$1.43

Net Profit Margin (Annual)4.08%

Month-to-Date Return-8.07%

EBITD / Share (Annual)$3.59

Operating Margin (Annual)7.78%

LT Debt / Equity (Annual)1.16x

P/CF (TTM)20.48x

P/E Excl Extra (TTM)45.71x

LT Debt / Equity (Quarterly)1.11x

EPS Basic Excl Extra (TTM)$1.19

P/B Ratio (Annual)4.97x

Pretax Margin (TTM)4.12%

Book Value / Share (Annual)$8.17

Price vs S&P 500 (13W)-31.95%

Beta1.16x

P/FCF (Annual)34.04x

Revenue / Share (TTM)$35.32

ROE (TTM)6.89%

52-Week Low$32.81

vGradeC

gGradeD

mGradeD

vgmGradeD

Show chart for

Earnings Surprise History

Q1 260.33est. 0.30

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.18

4.15

4.14

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53
GMEDGLOBUS MEDICAL INC	B	A	C	$80.00

About

Medline is the largest medical-surgical products and supply chain solutions provider in the United States, generating over 90% of its revenue domestically. The company serves major US health systems as a prime vendor, offering approximately 190,000 proprietary products and 150,000 third-party sourced products through an integrated supply chain. Backed by 30+ manufacturing facilities and over 2,000 owned delivery trucks, Medline leverages significant operational scale and logistics advantages. The company completed its IPO in December 2025.